NMN Dosage: How Much NMN Do Studies Use, and When Should You Take It?

Most human NMN trials have used an NMN dosage of 250 to 900 mg a day, usually for 6 to 12 weeks. A 2023 trial built to compare doses found that 600 mg raised blood NAD more than 300 mg, while 900 mg gave no statistically significant extra rise over 600 mg.

Timing is the easy part: morning and evening both have trial data behind them, so consistency and your label's directions matter more than the clock.

This guide puts the human trial doses in one table, shows what happened when researchers pushed the dose higher, and walks through timing, format and who should check with a clinician first. New to NMN altogether? Start with our NMN supplement guide for the basics, then come back for the numbers.

How much NMN do studies use?

Human trials have mostly given 250 to 900 mg of NMN a day, for anywhere from 6 to 12 weeks. That's the core range in the research. A few studies went higher to test safety or exercise performance.

Each trial measured something specific, such as blood NAD levels, physical performance, metabolic markers or safety lab work, and the format ranged from capsules to tablets to powder dissolved in water.

NMN doses and durations used in human trials

Study	Who took part	Daily dose	Duration	Main measure
Okabe 2022	30 healthy adults	250 mg (a 125 mg tablet twice a day)	12 weeks	Blood NAD+ and safety labs
Yoshino 2021	25 postmenopausal women with prediabetes and overweight or obesity	250 mg	10 weeks	Muscle metabolism markers
Kim 2022	108 older adults in Japan	250 mg once a day, morning or evening	12 weeks	Sleep, fatigue and physical performance by time of day
Yi 2023	80 healthy adults aged 40 to 65	300, 600 or 900 mg once a day (150 mg capsules)	60 days	Blood NAD, six-minute walk and safety
Liao 2021	48 recreational runners (40 men, 8 women)	300, 600 or 1,200 mg, split into two servings (powder)	6 weeks	Aerobic capacity during exercise
Fukamizu 2022	31 healthy adults aged 20 to 65	1,250 mg once a day (powder in water)	4 weeks	Safety measures

Safety data reach past that core range. In a 4-week trial of 31 healthy adults aged 20 to 65, 1,250 mg a day caused no changes beyond normal physiological variation in blood, urine or body-composition measures, and no severe adverse events.

A 2026 meta-analysis of 15 randomized trials covering 250 to 2,000 mg a day, for 14 days to 24 weeks, found no increase in overall, serious or withdrawal-related adverse events and no significant rise in the liver enzymes ALT and AST.

That's reassuring short-term tolerability data. It's a safety backstop, not a target to aim for.

Is more NMN better?

Not reliably. For blood NAD, the gains leveled off early in the main dose-comparison trial. In Yi and colleagues' 2023 trial, 80 healthy adults aged 40 to 65 took a placebo or 300, 600 or 900 mg of NMN once a day for 60 days.

Blood NAD (the trial's test counted NAD+ and its partner NADH together) rose in every NMN group, measured at day 30 and day 60 (p≤0.001). At day 60, average serum NAD was 11.8 nM with placebo, 32.6 nM with 300 mg, 45.3 nM with 600 mg and 48.5 nM with 900 mg.

Going from 300 to 600 mg pushed levels higher. Going from 600 to 900 mg made no statistically significant difference.

The six-minute walk test, a secondary measure in the same trial, followed the same pattern. All three NMN groups walked significantly farther than placebo at days 30 and 60, 600 mg beat 300 mg, and 900 mg showed no statistical difference from 600 mg. No adverse events were reported in the 600 or 900 mg groups.

Runners are where a higher dose kept moving a marker. In a 6-week trial of 48 recreational runners training five to six times a week, oxygen uptake and power at the ventilatory thresholds (the points during exercise where breathing ramps up sharply) improved more in the 600 and 1,200 mg groups than in the control group, and the authors describe that gain as dose-dependent.

VO2max and peak power, the headline fitness numbers, didn't change in any group, including the highest dose.

The supplement aisle loves a bigger number. The data are less impressed: blood NAD climbed with dose up to a point, and a dose-response for health outcomes hasn't been established. For the outcomes researchers have tracked so far, see what NMN trials measured.

How much NMN should you take per day?

Take the serving on your product's label. There's no established optimal NMN dose, and the trial range of 250 to 900 mg a day is wide enough that a single 500 mg capsule sits comfortably in the middle of it.

That's the practical answer to how much NMN per day: choose a product whose daily serving falls inside the range researchers have used, then take that serving every day.

Once a day or split? Both show up in the research. Yi's participants took their full dose once a day before breakfast, and Fukamizu's took 1,250 mg in a single daily serving. In Okabe's trial, the 250 mg came as two 125 mg tablets a day, and Liao's runners took two servings a day.

None of these trials compared split and single dosing head to head, so a once-daily capsule keeps the routine simple and easy to track.

On the regulatory side, NMN is sold in the US as a dietary supplement. In September 2025, the FDA concluded that NMN is not excluded from the dietary supplement definition, reversing the position it took in 2022.

That decision covers NMN's status. It doesn't approve any product or set a dose, so your label, plus your clinician's advice if you have a health condition, is your guide.

When is the best time to take NMN?

Pick a time you can stick to every day; the evidence doesn't lock you into one. Only one trial has tested timing head to head. Kim and colleagues (2022) gave 108 older adults in Japan 250 mg of NMN or a placebo once a day for 12 weeks, either in the morning (from waking until noon) or later in the day.

The paper calls the second group "afternoon," though its window actually ran from 6 p.m. to bedtime.

The later-day NMN group showed the largest effect sizes on two measures: the five-times sit-to-stand test, a measure of leg function (d=0.72), and drowsiness (d=0.64). The authors describe it as the first study of NMN timing in older adults, so treat it as a promising lead rather than a rule.

Morning works too. Yi's dose trial used a before-breakfast routine and still saw blood NAD climb at every dose. So here's the practical play: anchor NMN to a meal you eat every day, follow your label's food direction, and keep the time steady. If dinner is your most reliable meal, the Kim data give you no reason to avoid it.

How should you take NMN?

Swallow it with a meal, the way your label directs. The trials above used capsules, tablets and powder dissolved in water, and none of them crowned one format. Format mostly decides how easy the habit is.

In Yi's trial, NMN came in 150 mg capsules, so the 900 mg group swallowed six capsules every morning. A single 500 mg capsule is a much lighter lift.

What about holding NMN under your tongue? A 2026 crossover study in 14 healthy men gave a single 250 mg dose either sublingually or swallowed. Over 60 minutes, blood NMN, nicotinamide and NAD+ didn't differ significantly between the two routes, though two NMN breakdown products rose faster after the sublingual dose.

Liposomal, powder and sublingual options get their own full breakdown in NMN forms compared.

A few habits make the routine stick:

• Keep the bottle where you eat the meal you've paired it with.
• Take one serving at the same meal each day rather than chasing a perfect hour.
• Count servings, not capsules, when you compare products: the milligrams per serving are what match up with the trial table.

What if you miss a dose?

Take your next serving at the usual time and carry on. Don't double up to make up for it unless your label or clinician tells you to. The trials measured steady daily intake over weeks, so the daily habit is what counts, not any single day.

Who should talk to a clinician first?

Most healthy adults can simply follow the label. A few groups should get a professional opinion before starting:

• Pregnant or breastfeeding. None of the trials above studied pregnancy or breastfeeding, so there's no dose to point to.
• Living with a chronic condition. Most of the trials above enrolled healthy adults, so ask how NMN fits your situation.
• Taking prescription medicines. A pharmacist can check your full list, including other supplements.
• Under 18. Our label directions are written for adults.

If a new symptom shows up after you start, stop taking it and talk to a healthcare professional. Our guide to NMN side effects covers what trials reported and why some people stop.

Where our NMN capsule fits

Infinite Labs NMN gives you 500 mg of NMN in one veggie capsule a day, a single fixed dose squarely inside the 250 to 900 mg range most human trials used. No splitting, no scoops, no six-capsule mornings. The supporting ingredients are a plant-derived hypromellose capsule and Nu-FLOW, a rice-hull flow aid that keeps the powder from clumping during capsule filling.

Each bottle holds 60 servings, a two-month supply. The label direction: adults take 1 capsule daily with food, or as recommended by a qualified healthcare professional. It's third-party tested and made in GMP-certified facilities, and certificates of analysis are available on request. If you want one clearly dosed NMN capsule a day, it's a strong pick.

The takeaway

Human NMN trials mostly used 250 to 900 mg a day, and in the main trial that compared doses for blood NAD, going past 600 mg gave no statistically significant extra rise (48.5 vs 45.3 nM at day 60).

So follow your label, take it at a consistent time with a meal, and skip the megadose arms race. For the bigger picture on what NMN is and how to choose one, revisit our NMN supplement guide. If you're weighing NMN against NAD+ itself, see NMN vs NAD+.

Sources

• Yi et al. Efficacy and safety of NMN supplementation in healthy middle-aged adults: randomized, multicenter, double-blind, placebo-controlled, dose-dependent trial. GeroScience, 2023.
• Okabe et al. Oral administration of NMN is safe and efficiently increases blood NAD+ levels in healthy subjects. Frontiers in Nutrition, 2022.
• Kim et al. Effect of 12-week intake of NMN on sleep quality, fatigue and physical performance in older Japanese adults. Nutrients, 2022.
• Liao et al. NMN supplementation enhances aerobic capacity in amateur runners. Journal of the International Society of Sports Nutrition, 2021.
• Fukamizu et al. Safety evaluation of β-NMN oral administration in healthy adult men and women. Scientific Reports, 2022.
• Yang et al. Safety and metabolism-related outcomes of oral NMN supplementation in adults: systematic review and meta-analysis. Nutrients, 2026.
• Yoshino et al. Randomized, placebo-controlled NMN trial in postmenopausal women with prediabetes. Science, 2021.
• Wakabayashi et al. Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Scientific Reports, 2026.
• U.S. FDA. Response to citizen petition FDA-2023-P-0872 on β-NMN, September 2025.

Educational information, not medical advice. Infinite Labs NMN is not intended to diagnose, treat, cure, or prevent any disease.

About the author

Arjun Sareen is CEO of Infinite Labs and Infinite Labs Digital and a contributor to the Infinite Labs Journal. This brand-owned guide provides educational information, not individual medical advice.